These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8755859)

  • 21. Role of INTERLEUKIN-6 in the pathogenesis of multiple myeloma.
    Gadó K; Domján G; Hegyesi H; Falus A
    Cell Biol Int; 2000; 24(4):195-209. PubMed ID: 10816321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin-6 in the pathogenesis of rheumatoid arthritis.
    Park JY; Pillinger MH
    Bull NYU Hosp Jt Dis; 2007; 65 Suppl 1():S4-10. PubMed ID: 17708744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo models for studying the role of autocrine or paracrine growth factors in hematologic malignancies.
    Soma T; Dunbar CE
    Exp Hematol; 1995 May; 23(5):385-8. PubMed ID: 7720810
    [No Abstract]   [Full Text] [Related]  

  • 24. [Study of IL-6 signal transduction pathway in a human multiple myeloma cell line--Sko-007].
    Song L; Li Y; Shen B
    Zhonghua Xue Ye Xue Za Zhi; 2000 Nov; 21(11):569-71. PubMed ID: 11225245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A case of Castleman's disease complicated with nephrotic syndrome due to glomerulopathy mimicking membranoproliferative glomerulonephritis.
    Sugimoto T; Ito J; Takeda N; Gasyu I; Okazaki T; Sakaguchi M; Osawa N; Tanaka Y; Oka K; Uzu T; Kashiwagi A
    Am J Med Sci; 2008 Jun; 335(6):495-8. PubMed ID: 18552583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Growth factors in multiple myeloma].
    Klein B; Bataille R
    Presse Med; 1990 Dec; 19(43):1972-3. PubMed ID: 2149597
    [No Abstract]   [Full Text] [Related]  

  • 27. [Interleukin 6 and lymphoplasmocytic proliferation].
    Brouet JC; Lévy Y
    Nouv Rev Fr Hematol (1978); 1993 Jun; 35(3):225-6. PubMed ID: 8337132
    [No Abstract]   [Full Text] [Related]  

  • 28. Role of interleukin-6 in the progression of mesangial proliferative glomerulonephritis.
    Horii Y; Iwano M; Hirata E; Shiiki M; Fujii Y; Dohi K; Ishikawa H
    Kidney Int Suppl; 1993 Jan; 39():S71-5. PubMed ID: 8468929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal disease in POEMS syndrome: report on a case and review of the literature.
    Navis GJ; Dullaart RP; Vellenga E; Elema JD; de Jong PE
    Nephrol Dial Transplant; 1994; 9(10):1477-81. PubMed ID: 7816264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of pre-B cell colony-enhancing factor by STAT-3-dependent interleukin-6 trans-signaling: implications in the pathogenesis of rheumatoid arthritis.
    Nowell MA; Richards PJ; Fielding CA; Ognjanovic S; Topley N; Williams AS; Bryant-Greenwood G; Jones SA
    Arthritis Rheum; 2006 Jul; 54(7):2084-95. PubMed ID: 16802343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-6: biological features and clinical implications.
    Tafuto S; Silvestri I; D'Andrea P; Ronga D; Abate G
    J Biol Regul Homeost Agents; 1994; 8(1):1-8. PubMed ID: 7976490
    [No Abstract]   [Full Text] [Related]  

  • 32. Interleukin-6--a key mediator of systemic and local symptoms in rheumatoid arthritis.
    Cronstein BN
    Bull NYU Hosp Jt Dis; 2007; 65 Suppl 1():S11-5. PubMed ID: 17708739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Membranoproliferative glomerulonephritis, p-antineutrophil cytoplasmic antibodies, and rheumatoid arthritis. Report of a case.
    Constantin A; Laroche M; Moulinier L; Bon E; Mazières B; Cantagrel A
    Rev Rhum Engl Ed; 1996 Feb; 63(2):141-4. PubMed ID: 8689286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The sequestration function of the spleen. Research with devitalized erythrocytes].
    Pannacciulli I; Tizianello A; Gaetani G; Pastorini C
    Minerva Med; 1967 May; 58(43):1992-7. PubMed ID: 5339199
    [No Abstract]   [Full Text] [Related]  

  • 35. [Biology of interleukin-6. Role in lymphoplasmacytic hemopathies].
    Levy Y; Brouet JC
    Ann Med Interne (Paris); 1992; 143(8):533-43. PubMed ID: 1303597
    [No Abstract]   [Full Text] [Related]  

  • 36. Structure and function of the kidney in multiple myeloma.
    Schubert GE; Veigel J; Lennert K
    Virchows Arch A Pathol Pathol Anat; 1972; 355(2):135-57. PubMed ID: 4623024
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunotherapeutic implication of IL-6 blockade.
    Tanaka T; Kishimoto T
    Immunotherapy; 2012 Jan; 4(1):87-105. PubMed ID: 22150003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Interleukin-6 and epithelial tumours: new convincing arguments in favour of the use of IL-6 targeted therapies].
    Gougelet A; Mansuy A; Blay JY
    Med Sci (Paris); 2008; 24(8-9):694-6. PubMed ID: 18789212
    [No Abstract]   [Full Text] [Related]  

  • 39. Alleviation of systemic manifestations of multicentric Castleman's disease by thalidomide.
    Lee FC; Merchant SH
    Am J Hematol; 2003 May; 73(1):48-53. PubMed ID: 12701121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The evidence for interleukin-6 as an autocrine growth factor in malignancy.
    Akira S; Kishimoto T
    Semin Cancer Biol; 1992 Feb; 3(1):17-26. PubMed ID: 1643291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.